Literature DB >> 20871708

Quality performance improvement with the implementation of standard chemotherapy order forms.

Lena Dumasia1, Ellen Harris, Anibal Drelichman.   

Abstract

PURPOSE: Before October 2000, physicians in our institution handwrote chemotherapy orders on blank order sheets. There was no standard to which the physician could include variables that were crucial to the completeness of a chemotherapy order. For this reason, chemotherapy orders were frequently incomplete and had to be adjusted by the pharmacist after discussing the missing variables with the ordering physician. As a part of our goal to minimize errors, standard chemotherapy forms were initiated at our institution in October 2000.
METHODS: The first standard form implemented was a written order form that constituted a standard of the ideal variables necessary to accurately complete chemotherapy orders. These variables were the diagnosis, regimen, height, weight, body surface area (BSA), route, frequency, duration and chemotherapy dose and calculation based upon BSA. The next updated form was an electronic version similar to the original, and was implemented in April 2002.
RESULTS: From February 1999 to March 2000, using the traditional unstandardized blank order sheets, the average order completeness was 45%. After the standard written forms were introduced, from October 2000 to March 2002, the average chemotherapy order completeness was 81%, an improvement of 36%. Completeness improved to an average of 93% from April 2002 to December 2003, after the implementation of the electronic chemotherapy form.
CONCLUSION: Chemotherapy order completeness improves considerably through the standardization of chemotherapy order forms. The electronic forms show an additional improvement over handwritten forms. Electronic standardization of chemotherapy forms should be adopted as a best-practice model in hematology-oncology practices throughout the country.

Year:  2006        PMID: 20871708      PMCID: PMC2794599          DOI: 10.1200/JOP.2006.2.3.104

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  6 in total

1.  Human error: models and management.

Authors:  J Reason
Journal:  BMJ       Date:  2000-03-18

2.  A continuous-improvement approach for reducing the number of chemotherapy-related medication errors.

Authors:  B R Goldspiel; R DeChristoforo; C E Daniels
Journal:  Am J Health Syst Pharm       Date:  2000-12-15       Impact factor: 2.637

3.  Effect of implementing a cancer chemotherapy order form on prescribing habits for parenteral antineoplastics.

Authors:  D A Pastel; P Fay; D Lee
Journal:  Hosp Pharm       Date:  1993-12

4.  Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains.

Authors:  Richard B Womer; Ellen Tracy; Winson Soo-Hoo; Betsy Bickert; Susan DiTaranto; Jane H Barnsteiner
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

5.  Effect of a cancer chemotherapy prescription form on prescription completeness.

Authors:  D B Thorn; M G Sexton; A P Lemay; J S Sarigianis; D D Melita; N J Gustafson
Journal:  Am J Hosp Pharm       Date:  1989-09

Review 6.  Ten simple strategies to prevent chemotherapy errors.

Authors:  Lisa Schulmeister
Journal:  Clin J Oncol Nurs       Date:  2005-04       Impact factor: 1.027

  6 in total
  2 in total

1.  Adherence to a Standardized Chemotherapy Order form for Colorectal Cancer in a Referral Teaching Hospital, Mashhad, Iran.

Authors:  Mohamad-Mehdi Kooshyar; Anoosheh Maruzi; Azar Fani Pakdel; Sepideh Elyasi; Ali Taghizadeh-Kermani; Mahdi Akbarzadeh; Seyed Amir Aledavood
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

2.  Chemotherapy prescribing errors: an observational study on the role of information technology and computerized physician order entry systems.

Authors:  Marianna Aita; Ornella Belvedere; Elisa De Carlo; Laura Deroma; Federica De Pauli; Lorena Gurrieri; Angela Denaro; Loris Zanier; Gianpiero Fasola
Journal:  BMC Health Serv Res       Date:  2013-12-17       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.